5.29
Finanzdaten der Leonabio Inc-Aktie (LONA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
12.79%
12.70
|
11.26 | 6.712 | 2.825 | 3.661 |
| Costs And Expenses |
13.01%
19.45
|
17.21 | 78.56 | 6.874 | 7.291 |
| Operating Income/Loss |
13.01%
-19.45
|
-17.21 | -78.56 | -6.874 | -7.291 |
| Net Income/Loss |
42.31%
-19.01
|
-32.95 | -82.89 | -6.611 | -6.966 |
| Basic Average Shares |
24.70%
23.73
|
19.03 | - | 3.9439 | 39.09 |
| Diluted Average Shares |
24.70%
23.73
|
19.03 | - | 3.9439 | 39.09 |
| Basic Earnings Per Share |
53.76%
-0.80
|
-1.73 | - | -1.68 | -0.18 |
| Diluted Earnings Per Share |
53.76%
-0.80
|
-1.73 | - | -1.68 | -0.18 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):